One important point to remember with certain caveats.
Total Monthly Prescription Growth % Numbers Month over month
March 356 April 1614 353 May 3268 102 June 6150 88
Average based on the first 3 months = (353+102+88)/3 = 181% (as reported in the 2nd quarter results by Synergy)
If you add the sales figures for July, what we get is much lower, July 6203 1 Average based on the last 4 months = (353+102+88+1)/4 = 137%
If you look at the Bloomberg Table for recent prescription numbers for July and August(see link for prescription numbers shown in my earlier post), week over week sales growth is getting anemic.
Caveats Synergy claims a lot of activities are in the works and hopefully some of them may propel future sales and get the prescription number back to much higher levels.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.